mk 0663 has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanyal, SN; Setia, S; Vaish, V | 1 |
| Sanyal, SN; Setia, S | 1 |
2 other study(ies) available for mk 0663 and Experimental Neoplasms
| Article | Year |
|---|---|
Chemopreventive effects of NSAIDs as inhibitors of cyclooxygenase-2 and inducers of apoptosis in experimental lung carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bronchoalveolar Lavage Fluid; Carcinoma, Non-Small-Cell Lung; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; DNA Fragmentation; Drug Screening Assays, Antitumor; Etoricoxib; Female; Indomethacin; Lung; Lung Neoplasms; Membrane Proteins; Neoplasms, Experimental; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Sulfones; Tumor Burden | 2012 |
Downregulation of NF-κB and PCNA in the regulatory pathways of apoptosis by cyclooxygenase-2 inhibitors in experimental lung cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Carcinogens; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Etoricoxib; Gene Expression Regulation, Neoplastic; Lung Neoplasms; Male; Neoplasms, Experimental; NF-kappa B; Proliferating Cell Nuclear Antigen; Pyridines; Rats; Sulfones | 2012 |